Zacks Research Upgrades Sonic Healthcare (OTCMKTS:SKHHY) to Hold

Sonic Healthcare (OTCMKTS:SKHHY) was upgraded by investment analysts at Zacks Research from a “strong sell” rating to a “hold” rating in a research report issued on Monday, Zacks reports.

Separately, The Goldman Sachs Group cut Sonic Healthcare from a “buy” rating to a “hold” rating in a report on Sunday, October 11th. Two equities research analysts have rated the stock with a Hold rating and one has given a Sell rating to the company. According to MarketBeat, Sonic Healthcare presently has a consensus rating of “Reduce”.

Sonic Healthcare Trading Up 1.9%

Shares of SKHHY opened at $13.08 on Monday. The stock has a fifty day moving average of $13.87 and a two-hundred day moving average of $14.15. Sonic Healthcare has a fifty-two week low of $12.58 and a fifty-two week high of $17.49.

About Sonic Healthcare

Sonic Healthcare Limited is an Australian healthcare company specializing in medical diagnostics. Its principal business is laboratory medicine, providing pathology and clinical testing services used to diagnose, monitor and manage a broad range of medical conditions. The company serves hospitals, physicians, healthcare organizations and patients through networks of medical laboratories and collection centers.

Sonic Healthcare also operates medical imaging businesses in selected markets and provides related healthcare services, including occupational health and primary care offerings in Australia.